Gallneukirchen, Austria

Marina MÜLLER

This inventor holds 1 USPTO granted patent. Top assignee: Universität Linz. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marina MÜLLER. Retrieved from https://idiyas.com/inventor/marina-müller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marina Müller: Innovator in Tissue Damage Prevention

Introduction

Marina Müller is a prominent inventor based in Gallneukirchen, Austria. She has made significant contributions to the field of medical science, particularly in the prevention of tissue damage. Her innovative approach has garnered attention in the research community.

Latest Patents

Marina Müller holds a patent for the use of leoligin in the prevention of tissue damage. The patent describes the administration of leoligin or its derivatives systemically to subjects in need, aiming to prevent or reduce tissue damage. This invention highlights her commitment to advancing medical treatments and improving patient outcomes. She has 1 patent to her name.

Career Highlights

Marina is affiliated with the University of Linz, where she conducts her research and develops her inventions. Her work at the university has positioned her as a key figure in her field, contributing to both academic knowledge and practical applications in medicine.

Collaborations

Marina has collaborated with David Bernhard, enhancing her research efforts and expanding the impact of her work. Their partnership exemplifies the importance of teamwork in scientific innovation.

Conclusion

Marina Müller is a dedicated inventor whose work in tissue damage prevention showcases her innovative spirit and commitment to improving healthcare. Her contributions are paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…